Predict which early-stage biotechnology platforms (PROTAC, mRNA, gene editing, etc.) have the highest potential to become blockbuster therapies. Analyzes clinical trial progression, patent landscape maturity, and venture capital funding trends to generate investment and R&D prioritization scores. Trigger when: User asks about technology investment potential, platform selection, or therapeutic modality comparison.
Install with Tessl CLI
npx tessl i github:aipoch/medical-research-skills --skill blockbuster-therapy-predictor79
Does it follow best practices?
If you maintain this skill, you can automatically optimize it using the tessl CLI to improve its score:
npx tessl skill review --optimize ./path/to/skillValidation for skill structure
Comprehensive analytics tool for forecasting breakthrough therapeutic technologies by integrating multi-dimensional data sources including clinical development pipelines, intellectual property landscapes, and capital market indicators.
# Run complete analysis with all technologies
python scripts/main.py
# Analyze specific technologies
python scripts/main.py --tech PROTAC,mRNA,CRISPR
# Output in JSON format
python scripts/main.py --output json| Parameter | Type | Default | Required | Description |
|---|---|---|---|---|
--mode | str | full | No | Analysis mode: full or quick |
--tech | str | None | No | Comma-separated list of technologies to analyze |
--output | str | console | No | Output format: console or json |
--threshold | float | 0 | No | Minimum blockbuster index threshold (0-100) |
--save | str | None | No | Save report to file path |
# Analyze high-potential technologies only (index ≥70)
python scripts/main.py \
--threshold 70 \
--output json \
--save high_potential_report.json
# Quick analysis of specific platforms
python scripts/main.py \
--mode quick \
--tech CAR-T,ADC,Bispecific \
--output console🏆 BLOCKBUSTER THERAPY PREDICTOR Report
Generated: 2026-02-15 10:30:00
Technologies analyzed: 10
📊 Technology Rankings
Rank Technology Blockbuster Index Maturity Market Potential Momentum Recommendation
🥇 1 mRNA 85.2 78.5 92.1 88.0 Strongly Recommended
🥈 2 CAR-T 82.3 85.2 78.5 75.0 Strongly Recommended
🥉 3 CRISPR 79.8 72.3 88.2 68.0 Recommended{
"generated_at": "2026-02-15T10:30:00",
"total_routes": 10,
"rankings": [
{
"rank": 1,
"tech_name": "mRNA",
"blockbuster_index": 85.2,
"maturity_score": 78.5,
"market_potential_score": 92.1,
"momentum_score": 88.0,
"recommendation": "Strongly Recommended",
"key_drivers": ["Multiple Phase III trials", "Rapid patent growth"],
"risk_factors": ["Regulatory uncertainties"],
"timeline_prediction": "First product expected in 2-4 years"
}
]
}Blockbuster Index = (Market Potential × 0.5) + (Maturity × 0.3) + (Momentum × 0.2)| Component | Weight | Factors |
|---|---|---|
| Market Potential | 50% | Market size, unmet need, competition |
| Maturity | 30% | Clinical stage, patent depth, funding stage |
| Momentum | 20% | Patent growth, funding activity, clinical progress |
| Blockbuster Index | Recommendation | Action |
|---|---|---|
| ≥ 80 | Strongly Recommended | Prioritize R&D investment |
| 60-79 | Recommended | Active monitoring and early partnerships |
| 40-59 | Watch | Monitor milestones; reassess in 6-12 months |
| < 40 | Cautious | Minimal investment; consider divestment |
| Technology | Category | Description |
|---|---|---|
| PROTAC | Protein Degradation | Proteolysis Targeting Chimera |
| mRNA | Nucleic Acid Drugs | Messenger RNA therapy platform |
| CRISPR | Gene Editing | CRISPR-Cas gene editing technology |
| CAR-T | Cell Therapy | Chimeric Antigen Receptor T-cell therapy |
| Bispecific | Antibody Drugs | Bispecific antibody technology |
| ADC | Antibody Drugs | Antibody-Drug Conjugate |
| RNAi | Nucleic Acid Drugs | RNA interference therapy |
| Gene Therapy | Gene Therapy | AAV vector gene therapy |
| Allogeneic | Cell Therapy | Universal/Allogeneic cell therapy |
| Cell Therapy | Cell Therapy | General cell therapy platform |
⚠️ AI自主验收状态: 需人工检查
This skill requires:
pip install -r requirements.txtdataclasses
enum| Risk Indicator | Assessment | Level |
|---|---|---|
| Code Execution | Python scripts executed locally | Medium |
| Network Access | No external API calls in mock mode | Low |
| File System Access | Read/write report files only | Low |
| Instruction Tampering | Standard prompt guidelines | Low |
| Data Exposure | Output files saved to workspace | Low |
# Python dependencies
pip install -r requirements.txtSee references/ for:
⚠️ DISCLAIMER: This tool provides quantitative analysis for decision support only. All investment and R&D decisions should incorporate qualitative domain expertise, regulatory consultation, and comprehensive due diligence. Past performance of historical blockbusters does not guarantee future success of emerging technologies.
f11484c
If you maintain this skill, you can claim it as your own. Once claimed, you can manage eval scenarios, bundle related skills, attach documentation or rules, and ensure cross-agent compatibility.